bevacizumab in recurrent ovarian cancer
Published 6 years ago • 607 plays • Length 4:54Download video MP4
Download video MP3
Similar videos
-
7:32
bevacizumab for recurrent ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
0:52
dr. mirza on safety profile of niraparib/bevacizumab in recurrent ovarian cancer
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
8:15
bevacizumab in ovarian cancer
-
7:26
emerging therapies in recurrent ovarian cancer
-
7:24
ovarian cancer: maintenance following frontline bevacizumab
-
3:42
parp maintenance bevacizumab in ovarian cancer
-
4:03
upfront bevacizumab in advanced ovarian cancer
-
8:03
bevacizumab in platinum-sensitive ovarian cancer
-
1:05
dr. essel discusses long-term bevacizumab in ovarian cancer
-
6:34
bevacizumab’s value in recurrent ovarian cancer
-
1:19
dr. essel discusses adverse events of bevacizumab in ovarian cancer
-
1:30
dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
-
5:27
using maintenance therapy in recurrent ovarian cancer
-
1:30
dr. monk on bevacizumab in recurrent cervical cancer
-
1:12
dr. herzog on the optimal use of bevacizumab in patients with ovarian cancer